Featured Research

from universities, journals, and other organizations

Researchers Probe Mechanism Behind Heartbeat

Date:
July 22, 1997
Source:
University Of Texas-Houston Health Science Center
Summary:
Scientists at The University of Texas-Houston Medical School and the University of Alberta in Canada have determined the three-dimensional structure of cardiac troponin C (cardiac TnC), a protein responsible for regulating muscle contraction in the heart. Described in the July 18 edition of The Journal of Biological Chemistry, the work lays the foundation for the development of new drugs which can modify the properties of this critical molecular 'switch' and aid in the treatment of congestive heart failure.

Houston--(July 18, 1997)--Scientists at The University of Texas-Houston Medical School and the University of Alberta in Canada have determined the three-dimensional structure of cardiac troponin C (cardiac TnC), a protein responsible for regulating muscle contraction in the heart. Described in the July 18 edition of The Journal of Biological Chemistry, the work lays the foundation for the development of new drugs which can modify the properties of this critical molecular 'switch' and aid in the treatment of congestive heart failure.

Using nuclear magnetic resonance (NMR) spectroscopy and recombinant DNA techniques to model its three-dimensional solution structure, John Putkey, Ph.D., associate professor in the department of biochemistry & molecular biology at UT-Houston, in collaboration with Brian D. Sykes, Ph.D., professor of biochemistry at the University of Alberta, Edmonton, Canada, revealed elements of cardiac TnC which may help explain functional differences between cardiac and skeletal muscle contraction. Found only in heart muscle, cardiac TnC closely resembles skeletal TnC, one of a family of calcium-binding proteins which change shape as they relay biochemical signals which lead to muscle contraction. Now that the structure of cardiac TnC is known, researchers' ability to design clinically effective drugs will be significantly improved.

Dr. Putkey said: "A fundamental feature of the molecular mechanism of muscle regulation is a cyclic change in the three-dimensional conformation of the protein TnC as it binds and releases calcium. Troponin C can be conceptualized as a molecular switch: when calcium is bound, the muscle contracts--when calcium is released, the muscle relaxes. To fix or modify any machine one must know how it works. If that machine is a protein, then you need to know its three-dimensional structure. The structures of the cardiac and skeletal forms of TnC reveal profound and largely unexpected differences. These three-dimensional views provide valuable clues about how cardiac TnC works and how we may selectively modify its function."

Numerous studies have been conducted to identify drugs which increase cardiac TnC's affinity for calcium, thereby 'boosting' the action of heart muscle. These were based on the assumption that the drug-binding potential of cardiac TnC was similar to the skeletal form. The work of Putkey and Sykes will aid efforts to produce new therapies for heart attack patients who develop congestive heart failure -- the condition in which insufficient blood is pumped throughout the body. Treatment with appropriate calcium sensitizing drugs may help counter the heart muscle impairment found in these patients.

The NMR spectroscopy was conducted in Dr. Sykes' Edmonton laboratory where much of the earlier work on skeletal muscle troponin C took place. Commenting on his association with the UT-Houston team, Dr. Sykes said: "This has been an excellent collaboration bringing together the different expertise of the Houston and Edmonton research teams. The structure of cardiac TnC has revealed some quite unexpected features, and will go a long way towards explaining both the differences between cardiac and skeletal muscle contraction and also, on a very molecular level, how calcium binding to regulatory proteins such as TnC is linked to their triggering function in many biological systems."

Note to editors: The authors of 'NMR Structure of Cardiac Troponin C Reveals an Unexpected Closed Regulatory Domain' are Samuel K. Sia, Monica X. Li, Leo Spyracopoulos, Stephanie M. Gagne, Wen Liu, John A. Putkey and Brian D. Sykes*. * Corresponding Author.


Story Source:

The above story is based on materials provided by University Of Texas-Houston Health Science Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas-Houston Health Science Center. "Researchers Probe Mechanism Behind Heartbeat." ScienceDaily. ScienceDaily, 22 July 1997. <www.sciencedaily.com/releases/1997/07/970722054753.htm>.
University Of Texas-Houston Health Science Center. (1997, July 22). Researchers Probe Mechanism Behind Heartbeat. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1997/07/970722054753.htm
University Of Texas-Houston Health Science Center. "Researchers Probe Mechanism Behind Heartbeat." ScienceDaily. www.sciencedaily.com/releases/1997/07/970722054753.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins